The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I study of weekly intraperitoneal paclitaxel combined with S-1 and oxaliplatin for gastric cancer with peritoneal metastasis.
Hironori Ishigami
No relevant relationships to disclose
Shoichi Kaisaki
No relevant relationships to disclose
Hironori Yamaguchi
No relevant relationships to disclose
Hiroharu Yamashita
No relevant relationships to disclose
Shigenobu Emoto
No relevant relationships to disclose
Joji Kitayama
No relevant relationships to disclose